Company intelligence / Profile preview

Cureety

Ownership: Private
Employees: ~30
Development stage: Other

Overview

Cureety has developed a CE-marked Class IIa medical device software that enables remote monitoring of cancer patients. Its clinical classification algorithms and personalized questionnaires provide tailored support between consultations, guide patients to appropriate care, help caregivers prioritize resources, and contribute real-world data for research. The solution is used by major hospitals and has monitored nearly 5,000 patients as of early 2022.

Therapeutic areas: Oncology
Modalities: Non-pharmacological therapyDevice (specifically, digital health platform/software for remote monitoring)
Industry: Digital Health Medical Devices

Partnerships

AstraZeneca France & SpainServierIpsenTeladoc Health FranceRennes University HospitalRouen University HospitalLéon Bérard CenterFrench Army Health Service

Beyond the preview

Go deeper on Cureety.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Cureety.

Explore the full profile